Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Hepatology
; 64(2): 370-80, 2016 08.
Article
in En
| MEDLINE
| ID: mdl-26799692
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepacivirus
/
Hepatitis C, Chronic
/
Simeprevir
/
Sofosbuvir
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hepatology
Year:
2016
Document type:
Article
Affiliation country:
India
Country of publication:
United States